Pulse Biosciences, Inc.
PLSE
$17.19
$0.704.25%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 27.78M | 23.92M | 19.06M | 16.88M | 15.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.69M | 56.26M | 48.53M | 46.13M | 44.63M |
| Operating Income | -63.69M | -56.26M | -48.53M | -46.13M | -44.63M |
| Income Before Tax | -60.24M | -53.59M | -46.13M | -44.02M | -42.55M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -60.24 | -53.59 | -46.13 | -44.02 | -42.55 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -60.24M | -53.59M | -46.13M | -44.02M | -42.55M |
| EBIT | -63.69M | -56.26M | -48.53M | -46.13M | -44.63M |
| EBITDA | -62.52M | -55.08M | -47.33M | -44.93M | -43.42M |
| EPS Basic | -0.97 | -0.90 | -0.80 | -0.78 | -0.80 |
| Normalized Basic EPS | -0.61 | -0.56 | -0.50 | -0.49 | -0.50 |
| EPS Diluted | -0.97 | -0.90 | -0.80 | -0.78 | -0.80 |
| Normalized Diluted EPS | -0.61 | -0.56 | -0.50 | -0.49 | -0.50 |
| Average Basic Shares Outstanding | 247.43M | 237.43M | 230.43M | 226.23M | 215.13M |
| Average Diluted Shares Outstanding | 247.43M | 237.43M | 230.43M | 226.23M | 215.13M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |